VANCOUVER, March 19, 2018 /PRNewswire/ – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Company is changing its ticker on the TSX Venture Exchange from IMH to GENE effective on March 20, 2018.
“The change…
